MedTrace Logo

Role of Fasted Exercise on Improving Cardiometabolic Health

NCT05742373 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-03-07

No results posted yet for this study

Summary

The aim of this randomised control trial is to investigate the role of fasted exercise on cardiometabolic health. Participants will be assigned to one of three conditions, fasted exercise, fed exercise and control (no exercise). Participants in the exercise groups will complete four weeks of moderate intensity cycling exercise, three times per week, either in the fasted or fed state according to their group assignment. Experimental trials involving anthropometric and cardiometabolic disease risk factor measurements as well as metabolic responses to a subsequent meal ingestion following exercise will be compared pre-intervention and post intervention.

Conditions

Interventions

OTHER

Exercise training in the fasted state

Four weeks of moderate intensity cycling exercise, three times a week without eating breakfast meal

OTHER

Exercise training in the fed state

Four weeks of moderate intensity cycling exercise, three times a week, after eating breakfast meal

Sponsors & Collaborators

  • European Society for Clinical Nutrition and Metabolism

    collaborator OTHER

  • Manchester Metropolitan University

    lead OTHER

Principal Investigators

  • Adora Yau, PhD · Manchester Metropolitan University

  • Gethin Evans, PhD · Manchester Metropolitan University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2025-04-30
Completion
2025-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05742373 on ClinicalTrials.gov